O’Sullivan, Gerard J.
de Graaf, Rick
Black, Steven A.
Article History
Received: 17 February 2018
Accepted: 20 June 2018
First Online: 26 June 2018
Compliance with Ethical Standards
:
: In the ATTRACT trial, two devices were used, Trellis (Medtronic, Galway, Ireland) and AngioJet (Boston Scientific, Galway, Ireland). Within the past 24 months, each of the authors has served on a paid Scientific Advisory Board, or been on a paid speaker panel for one or other of these two companies. None of these were in any way related to the ATTRACT trial. We can confirm that the above have made no difference whatsoever to our submission; especially the Trellis device is no longer commercially available, and the AngioJet device used in the trial is no longer the primary thrombectomy device available from Boston Scientific.